Stockreport

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

Genelux Corporation  (GNLX) 
PDF WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today annou [Read more]